Contact Information

Call us at: (614) 722-4425

Fax us at: (614) 722-4440

PediatricsEndocrinology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Kathryn Stephens Obrynba

Biography

Kathryn S. Obrynba, MD, is a member of the Section of Endocrinology at Nationwide Children’s Hospital and an assistant professor of Pediatrics at The Ohio State University College of Medicine. Dr. Obrynba received her undergraduate and medical degrees from West Virginia University. She completed her internship and Pediatric residency at Nationwide Children’s Hospital in 2010, went on to serve as chief resident, and completed her Pediatric Endocrinology fellowship at Nationwide Children’s Hospital in 2014. Dr. Obrynba is certified by the American Board of Pediatrics and the American Board of Pediatric Endocrinology. Her clinical and research interests include type 1 diabetes, Prader Willi syndrome and 22q11 deletion syndrome. Her administrative roles include Quality Improvement and serving on the Pediatric Residency Interview Committee. Dr. Obrynba is a professional member of The Endocrine Society and Pediatric Endocrine Society.

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Dublin Close To Home Center at 5665 Venture Drive

Academic and Clinical Areas

22q Center

Physician Team

Prader-Willi Syndrome Clinic

Physician Team

Endocrinology

Physician Team

Endocrinology Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Endocrinology

Awards, Honors & Organizations

Member, The Endocrine Society Member, Pediatric Endocrine Society

Research

Publications

                  Miller JL, Gevers E, Bridges N, Yanovski JA, Salehi P, Obrynba KS, Felner EI, Bird LM, Shoemaker AH, Angulo M, Butler MG, Stevenson D, Abuzzahab J, Barrett T, Lah M, Littlejohn E, Mathew V, Cowen NM, Bhatnagar A. Diazoxide Choline Extended-Release Tablet in People with Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial. J Clin Endocrinol Metab. 2023 Jan 14;  

                


                  Roof E, Deal CL, McCandless SE, Cowan RL, Miller JL, Hamilton JK, Roeder ER, McCormack SE, Roshan Lal TR, Abdul-Latif HD, Haqq AM, Obrynba KS, Torchen LC, Vidmar AP, Viskochil DH, Chanoine JP, Lam CKL, Pierce MJ, Williams LL, Bird LM, Butler MG, Jensen DE, Myers SE, Oatman OJ, Baskaran C, Chalmers LJ, Fu C, Alos N, McLean SD, Shah A, Whitman BY, Blumenstein BA, Leonard SF, Ernest JP, Cormier JW, Cotter SP, Ryman DC. Intranasal Carbetocin Reduces Hyperphagia, Anxiousness and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial. J Clin Endocrinol Metab. 2023 Jan 12;  

                


                  Garey CJ, Clements MA, McAuliffe-Fogarty AH, Obrynba KS, Weinstock RS, Majidi S, Ross CS, Rioles NA. The association between depression symptom endorsement and glycemic outcomes in adolescents with type 1 diabetes. Pediatr Diabetes. 2021 Nov 14;  

                


                  Obrynba KS, Anglin K, Moffett A, Steinke T, Kamboj MK. A Quality Improvement Project to Implement Choking Prevention and First Aid Education in Prader-Willi Syndrome Caregivers. J Clin Med. 2021 Oct 27; 10: 

                


                  DeSalvo DJ, Noor N, Xie C, Corathers SD, Majidi S, McDonough RJ, Polsky S, Izquierdo R, Rioles N, Weinstock R, Obrynba K, Roberts A, Vendrame F, Sanchez J, Ebekozien O. Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data From T1D Exchange Real-World Observational Study. J Diabetes Sci Technol. 2021 Oct 9;  19322968211049783.

                


                  Prahalad P, Ebekozien O, Alonso GT, Clements M, Corathers S, DeSalvo D, Desimone M, Lee JM, Lorincz I, McDonough R, Majidi S, Odugbesan O, Obrynba K, Rioles N, Kamboj M, Jones NY, Maahs DM. Multi-Clinic Quality Improvement Initiative Increases Continuous Glucose Monitoring Use Among Adolescents and Young Adults With Type 1 Diabetes. Clin Diabetes. 2021 Jul; 39: 264-271.

                


                  Ginnard OZB, Alonso GT, Corathers SD, Demeterco-Berggren C, Golden LH, Miyazaki BT, Nelson G, Ospelt E, Ebekozien O, Lee JM, Obrynba KS, DeSalvo DJ. Quality Improvement in Diabetes Care: A Review of Initiatives and Outcomes in the T1D Exchange Quality Improvement Collaborative. Clin Diabetes. 2021 Jul; 39: 256-263.

                


                  Obrynba KS, Hoffman RP, Repaske DR, Anglin K, Kamboj MK. No central adrenal insufficiency found in patients with Prader-Willi syndrome with an overnight metyrapone test. J Pediatr Endocrinol Metab. 2018 Jul 26; 31: 809-814.

                


                  Glick BA, Hong KMC, Obrynba K, Kamboj MK, Hoffman RP. Identifying depressive symptoms among diabetes type and the impact on hemoglobin A1c. J Pediatr Endocrinol Metab. 2018 Jan 26; 31: 39-44.

View More Publications

Education

Date of Appointment at Nationwide Children’s Hospital: 07/01/2010

Board Certifications

Pediatric Endocrinology Pediatrics

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2014

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/2010

Medical School

West Virginia University School of Medicine

Date Completed: 05/13/2007

Contact Information

Pediatrics

Call us at: (614) 722-4425

Fax us at: (614) 722-4440

                    Endocrinology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Call us at: (614) 722-4425

Fax us at: (614) 722-4440

PediatricsEndocrinology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Kathryn Stephens Obrynba

Biography

Kathryn S. Obrynba, MD, is a member of the Section of Endocrinology at Nationwide Children’s Hospital and an assistant professor of Pediatrics at The Ohio State University College of Medicine. Dr. Obrynba received her undergraduate and medical degrees from West Virginia University. She completed her internship and Pediatric residency at Nationwide Children’s Hospital in 2010, went on to serve as chief resident, and completed her Pediatric Endocrinology fellowship at Nationwide Children’s Hospital in 2014. Dr. Obrynba is certified by the American Board of Pediatrics and the American Board of Pediatric Endocrinology. Her clinical and research interests include type 1 diabetes, Prader Willi syndrome and 22q11 deletion syndrome. Her administrative roles include Quality Improvement and serving on the Pediatric Residency Interview Committee. Dr. Obrynba is a professional member of The Endocrine Society and Pediatric Endocrine Society.

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Dublin Close To Home Center at 5665 Venture Drive

Academic and Clinical Areas

22q Center

Physician Team

Prader-Willi Syndrome Clinic

Physician Team

Endocrinology

Physician Team

Endocrinology Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Endocrinology

Awards, Honors & Organizations

Member, The Endocrine Society Member, Pediatric Endocrine Society

Research

Publications

                  Miller JL, Gevers E, Bridges N, Yanovski JA, Salehi P, Obrynba KS, Felner EI, Bird LM, Shoemaker AH, Angulo M, Butler MG, Stevenson D, Abuzzahab J, Barrett T, Lah M, Littlejohn E, Mathew V, Cowen NM, Bhatnagar A. Diazoxide Choline Extended-Release Tablet in People with Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial. J Clin Endocrinol Metab. 2023 Jan 14;  

                


                  Roof E, Deal CL, McCandless SE, Cowan RL, Miller JL, Hamilton JK, Roeder ER, McCormack SE, Roshan Lal TR, Abdul-Latif HD, Haqq AM, Obrynba KS, Torchen LC, Vidmar AP, Viskochil DH, Chanoine JP, Lam CKL, Pierce MJ, Williams LL, Bird LM, Butler MG, Jensen DE, Myers SE, Oatman OJ, Baskaran C, Chalmers LJ, Fu C, Alos N, McLean SD, Shah A, Whitman BY, Blumenstein BA, Leonard SF, Ernest JP, Cormier JW, Cotter SP, Ryman DC. Intranasal Carbetocin Reduces Hyperphagia, Anxiousness and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial. J Clin Endocrinol Metab. 2023 Jan 12;  

                


                  Garey CJ, Clements MA, McAuliffe-Fogarty AH, Obrynba KS, Weinstock RS, Majidi S, Ross CS, Rioles NA. The association between depression symptom endorsement and glycemic outcomes in adolescents with type 1 diabetes. Pediatr Diabetes. 2021 Nov 14;  

                


                  Obrynba KS, Anglin K, Moffett A, Steinke T, Kamboj MK. A Quality Improvement Project to Implement Choking Prevention and First Aid Education in Prader-Willi Syndrome Caregivers. J Clin Med. 2021 Oct 27; 10: 

                


                  DeSalvo DJ, Noor N, Xie C, Corathers SD, Majidi S, McDonough RJ, Polsky S, Izquierdo R, Rioles N, Weinstock R, Obrynba K, Roberts A, Vendrame F, Sanchez J, Ebekozien O. Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data From T1D Exchange Real-World Observational Study. J Diabetes Sci Technol. 2021 Oct 9;  19322968211049783.

                


                  Prahalad P, Ebekozien O, Alonso GT, Clements M, Corathers S, DeSalvo D, Desimone M, Lee JM, Lorincz I, McDonough R, Majidi S, Odugbesan O, Obrynba K, Rioles N, Kamboj M, Jones NY, Maahs DM. Multi-Clinic Quality Improvement Initiative Increases Continuous Glucose Monitoring Use Among Adolescents and Young Adults With Type 1 Diabetes. Clin Diabetes. 2021 Jul; 39: 264-271.

                


                  Ginnard OZB, Alonso GT, Corathers SD, Demeterco-Berggren C, Golden LH, Miyazaki BT, Nelson G, Ospelt E, Ebekozien O, Lee JM, Obrynba KS, DeSalvo DJ. Quality Improvement in Diabetes Care: A Review of Initiatives and Outcomes in the T1D Exchange Quality Improvement Collaborative. Clin Diabetes. 2021 Jul; 39: 256-263.

                


                  Obrynba KS, Hoffman RP, Repaske DR, Anglin K, Kamboj MK. No central adrenal insufficiency found in patients with Prader-Willi syndrome with an overnight metyrapone test. J Pediatr Endocrinol Metab. 2018 Jul 26; 31: 809-814.

                


                  Glick BA, Hong KMC, Obrynba K, Kamboj MK, Hoffman RP. Identifying depressive symptoms among diabetes type and the impact on hemoglobin A1c. J Pediatr Endocrinol Metab. 2018 Jan 26; 31: 39-44.

View More Publications

Education

Date of Appointment at Nationwide Children’s Hospital: 07/01/2010

Board Certifications

Pediatric Endocrinology Pediatrics

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2014

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/2010

Medical School

West Virginia University School of Medicine

Date Completed: 05/13/2007

Contact Information

Pediatrics

Call us at: (614) 722-4425

Fax us at: (614) 722-4440

                    Endocrinology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Call us at: (614) 722-4425

Fax us at: (614) 722-4440

PediatricsEndocrinology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Kathryn Stephens Obrynba

Contact Information

  • Call us at:
  • (614) 722-4425
  • Fax us at:
  • (614) 722-4440
  • PediatricsEndocrinology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Kathryn Stephens Obrynba

Biography

Kathryn S. Obrynba, MD, is a member of the Section of Endocrinology at Nationwide Children’s Hospital and an assistant professor of Pediatrics at The Ohio State University College of Medicine. Dr. Obrynba received her undergraduate and medical degrees from West Virginia University. She completed her internship and Pediatric residency at Nationwide Children’s Hospital in 2010, went on to serve as chief resident, and completed her Pediatric Endocrinology fellowship at Nationwide Children’s Hospital in 2014. Dr. Obrynba is certified by the American Board of Pediatrics and the American Board of Pediatric Endocrinology. Her clinical and research interests include type 1 diabetes, Prader Willi syndrome and 22q11 deletion syndrome. Her administrative roles include Quality Improvement and serving on the Pediatric Residency Interview Committee. Dr. Obrynba is a professional member of The Endocrine Society and Pediatric Endocrine Society.

Biography

Kathryn S. Obrynba, MD, is a member of the Section of Endocrinology at Nationwide Children’s Hospital and an assistant professor of Pediatrics at The Ohio State University College of Medicine. Dr. Obrynba received her undergraduate and medical degrees from West Virginia University. She completed her internship and Pediatric residency at Nationwide Children’s Hospital in 2010, went on to serve as chief resident, and completed her Pediatric Endocrinology fellowship at Nationwide Children’s Hospital in 2014. Dr. Obrynba is certified by the American Board of Pediatrics and the American Board of Pediatric Endocrinology. Her clinical and research interests include type 1 diabetes, Prader Willi syndrome and 22q11 deletion syndrome. Her administrative roles include Quality Improvement and serving on the Pediatric Residency Interview Committee. Dr. Obrynba is a professional member of The Endocrine Society and Pediatric Endocrine Society.

Biography

Kathryn S. Obrynba, MD, is a member of the Section of Endocrinology at Nationwide Children’s Hospital and an assistant professor of Pediatrics at The Ohio State University College of Medicine. Dr. Obrynba received her undergraduate and medical degrees from West Virginia University. She completed her internship and Pediatric residency at Nationwide Children’s Hospital in 2010, went on to serve as chief resident, and completed her Pediatric Endocrinology fellowship at Nationwide Children’s Hospital in 2014. Dr. Obrynba is certified by the American Board of Pediatrics and the American Board of Pediatric Endocrinology. Her clinical and research interests include type 1 diabetes, Prader Willi syndrome and 22q11 deletion syndrome. Her administrative roles include Quality Improvement and serving on the Pediatric Residency Interview Committee. Dr. Obrynba is a professional member of The Endocrine Society and Pediatric Endocrine Society.

Kathryn S. Obrynba, MD, is a member of the Section of Endocrinology at Nationwide Children’s Hospital and an assistant professor of Pediatrics at The Ohio State University College of Medicine. Dr. Obrynba received her undergraduate and medical degrees from West Virginia University. She completed her internship and Pediatric residency at Nationwide Children’s Hospital in 2010, went on to serve as chief resident, and completed her Pediatric Endocrinology fellowship at Nationwide Children’s Hospital in 2014. Dr. Obrynba is certified by the American Board of Pediatrics and the American Board of Pediatric Endocrinology. Her clinical and research interests include type 1 diabetes, Prader Willi syndrome and 22q11 deletion syndrome. Her administrative roles include Quality Improvement and serving on the Pediatric Residency Interview Committee. Dr. Obrynba is a professional member of The Endocrine Society and Pediatric Endocrine Society.

Kathryn S. Obrynba, MD, is a member of the Section of Endocrinology at Nationwide Children’s Hospital and an assistant professor of Pediatrics at The Ohio State University College of Medicine. Dr. Obrynba received her undergraduate and medical degrees from West Virginia University. She completed her internship and Pediatric residency at Nationwide Children’s Hospital in 2010, went on to serve as chief resident, and completed her Pediatric Endocrinology fellowship at Nationwide Children’s Hospital in 2014.

Dr. Obrynba is certified by the American Board of Pediatrics and the American Board of Pediatric Endocrinology. Her clinical and research interests include type 1 diabetes, Prader Willi syndrome and 22q11 deletion syndrome. Her administrative roles include Quality Improvement and serving on the Pediatric Residency Interview Committee. Dr. Obrynba is a professional member of The Endocrine Society and Pediatric Endocrine Society.

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Dublin Close To Home Center at 5665 Venture Drive

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Dublin Close To Home Center at 5665 Venture Drive

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Dublin Close To Home Center at 5665 Venture Drive

Locations

Main Campus of Nationwide Children’s Hospital

Dublin Close To Home Center at 5665 Venture Drive

Locations

Main Campus of Nationwide Children’s Hospital

Dublin Close To Home Center at 5665 Venture Drive

Locations

Main Campus of Nationwide Children’s Hospital

Dublin Close To Home Center at 5665 Venture Drive

  • Main Campus of Nationwide Children’s Hospital
  • Dublin Close To Home Center at 5665 Venture Drive

Academic and Clinical Areas

22q Center

Physician Team

Prader-Willi Syndrome Clinic

Physician Team

Endocrinology

Physician Team

Endocrinology Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Endocrinology

Academic and Clinical Areas

22q Center

Physician Team

Prader-Willi Syndrome Clinic

Physician Team

Endocrinology

Physician Team

Endocrinology Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Endocrinology

Academic and Clinical Areas

22q Center

Physician Team

Prader-Willi Syndrome Clinic

Physician Team

Endocrinology

Physician Team

Endocrinology Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Endocrinology

22q Center

Physician Team

Prader-Willi Syndrome Clinic

Physician Team

Endocrinology

Physician Team

Endocrinology Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Endocrinology

  • 22q Center
  • Physician Team
  • Prader-Willi Syndrome Clinic
  • Physician Team
  • Endocrinology
  • Physician Team
  • Endocrinology Fellowship
  • Faculty
  • Primary Department
  • Pediatrics
  • Primary Section
  • Endocrinology

Awards, Honors & Organizations

Member, The Endocrine Society Member, Pediatric Endocrine Society

Awards, Honors & Organizations

Member, The Endocrine Society Member, Pediatric Endocrine Society

Awards, Honors & Organizations

Member, The Endocrine Society Member, Pediatric Endocrine Society

Member, The Endocrine Society Member, Pediatric Endocrine Society

  • Member, The Endocrine Society
  • Member, Pediatric Endocrine Society

Research

Publications

                  Miller JL, Gevers E, Bridges N, Yanovski JA, Salehi P, Obrynba KS, Felner EI, Bird LM, Shoemaker AH, Angulo M, Butler MG, Stevenson D, Abuzzahab J, Barrett T, Lah M, Littlejohn E, Mathew V, Cowen NM, Bhatnagar A. Diazoxide Choline Extended-Release Tablet in People with Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial. J Clin Endocrinol Metab. 2023 Jan 14;  

                


                  Roof E, Deal CL, McCandless SE, Cowan RL, Miller JL, Hamilton JK, Roeder ER, McCormack SE, Roshan Lal TR, Abdul-Latif HD, Haqq AM, Obrynba KS, Torchen LC, Vidmar AP, Viskochil DH, Chanoine JP, Lam CKL, Pierce MJ, Williams LL, Bird LM, Butler MG, Jensen DE, Myers SE, Oatman OJ, Baskaran C, Chalmers LJ, Fu C, Alos N, McLean SD, Shah A, Whitman BY, Blumenstein BA, Leonard SF, Ernest JP, Cormier JW, Cotter SP, Ryman DC. Intranasal Carbetocin Reduces Hyperphagia, Anxiousness and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial. J Clin Endocrinol Metab. 2023 Jan 12;  

                


                  Garey CJ, Clements MA, McAuliffe-Fogarty AH, Obrynba KS, Weinstock RS, Majidi S, Ross CS, Rioles NA. The association between depression symptom endorsement and glycemic outcomes in adolescents with type 1 diabetes. Pediatr Diabetes. 2021 Nov 14;  

                


                  Obrynba KS, Anglin K, Moffett A, Steinke T, Kamboj MK. A Quality Improvement Project to Implement Choking Prevention and First Aid Education in Prader-Willi Syndrome Caregivers. J Clin Med. 2021 Oct 27; 10: 

                


                  DeSalvo DJ, Noor N, Xie C, Corathers SD, Majidi S, McDonough RJ, Polsky S, Izquierdo R, Rioles N, Weinstock R, Obrynba K, Roberts A, Vendrame F, Sanchez J, Ebekozien O. Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data From T1D Exchange Real-World Observational Study. J Diabetes Sci Technol. 2021 Oct 9;  19322968211049783.

                


                  Prahalad P, Ebekozien O, Alonso GT, Clements M, Corathers S, DeSalvo D, Desimone M, Lee JM, Lorincz I, McDonough R, Majidi S, Odugbesan O, Obrynba K, Rioles N, Kamboj M, Jones NY, Maahs DM. Multi-Clinic Quality Improvement Initiative Increases Continuous Glucose Monitoring Use Among Adolescents and Young Adults With Type 1 Diabetes. Clin Diabetes. 2021 Jul; 39: 264-271.

                


                  Ginnard OZB, Alonso GT, Corathers SD, Demeterco-Berggren C, Golden LH, Miyazaki BT, Nelson G, Ospelt E, Ebekozien O, Lee JM, Obrynba KS, DeSalvo DJ. Quality Improvement in Diabetes Care: A Review of Initiatives and Outcomes in the T1D Exchange Quality Improvement Collaborative. Clin Diabetes. 2021 Jul; 39: 256-263.

                


                  Obrynba KS, Hoffman RP, Repaske DR, Anglin K, Kamboj MK. No central adrenal insufficiency found in patients with Prader-Willi syndrome with an overnight metyrapone test. J Pediatr Endocrinol Metab. 2018 Jul 26; 31: 809-814.

                


                  Glick BA, Hong KMC, Obrynba K, Kamboj MK, Hoffman RP. Identifying depressive symptoms among diabetes type and the impact on hemoglobin A1c. J Pediatr Endocrinol Metab. 2018 Jan 26; 31: 39-44.

View More Publications

Research

Publications

                  Miller JL, Gevers E, Bridges N, Yanovski JA, Salehi P, Obrynba KS, Felner EI, Bird LM, Shoemaker AH, Angulo M, Butler MG, Stevenson D, Abuzzahab J, Barrett T, Lah M, Littlejohn E, Mathew V, Cowen NM, Bhatnagar A. Diazoxide Choline Extended-Release Tablet in People with Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial. J Clin Endocrinol Metab. 2023 Jan 14;  

                


                  Roof E, Deal CL, McCandless SE, Cowan RL, Miller JL, Hamilton JK, Roeder ER, McCormack SE, Roshan Lal TR, Abdul-Latif HD, Haqq AM, Obrynba KS, Torchen LC, Vidmar AP, Viskochil DH, Chanoine JP, Lam CKL, Pierce MJ, Williams LL, Bird LM, Butler MG, Jensen DE, Myers SE, Oatman OJ, Baskaran C, Chalmers LJ, Fu C, Alos N, McLean SD, Shah A, Whitman BY, Blumenstein BA, Leonard SF, Ernest JP, Cormier JW, Cotter SP, Ryman DC. Intranasal Carbetocin Reduces Hyperphagia, Anxiousness and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial. J Clin Endocrinol Metab. 2023 Jan 12;  

                


                  Garey CJ, Clements MA, McAuliffe-Fogarty AH, Obrynba KS, Weinstock RS, Majidi S, Ross CS, Rioles NA. The association between depression symptom endorsement and glycemic outcomes in adolescents with type 1 diabetes. Pediatr Diabetes. 2021 Nov 14;  

                


                  Obrynba KS, Anglin K, Moffett A, Steinke T, Kamboj MK. A Quality Improvement Project to Implement Choking Prevention and First Aid Education in Prader-Willi Syndrome Caregivers. J Clin Med. 2021 Oct 27; 10: 

                


                  DeSalvo DJ, Noor N, Xie C, Corathers SD, Majidi S, McDonough RJ, Polsky S, Izquierdo R, Rioles N, Weinstock R, Obrynba K, Roberts A, Vendrame F, Sanchez J, Ebekozien O. Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data From T1D Exchange Real-World Observational Study. J Diabetes Sci Technol. 2021 Oct 9;  19322968211049783.

                


                  Prahalad P, Ebekozien O, Alonso GT, Clements M, Corathers S, DeSalvo D, Desimone M, Lee JM, Lorincz I, McDonough R, Majidi S, Odugbesan O, Obrynba K, Rioles N, Kamboj M, Jones NY, Maahs DM. Multi-Clinic Quality Improvement Initiative Increases Continuous Glucose Monitoring Use Among Adolescents and Young Adults With Type 1 Diabetes. Clin Diabetes. 2021 Jul; 39: 264-271.

                


                  Ginnard OZB, Alonso GT, Corathers SD, Demeterco-Berggren C, Golden LH, Miyazaki BT, Nelson G, Ospelt E, Ebekozien O, Lee JM, Obrynba KS, DeSalvo DJ. Quality Improvement in Diabetes Care: A Review of Initiatives and Outcomes in the T1D Exchange Quality Improvement Collaborative. Clin Diabetes. 2021 Jul; 39: 256-263.

                


                  Obrynba KS, Hoffman RP, Repaske DR, Anglin K, Kamboj MK. No central adrenal insufficiency found in patients with Prader-Willi syndrome with an overnight metyrapone test. J Pediatr Endocrinol Metab. 2018 Jul 26; 31: 809-814.

                


                  Glick BA, Hong KMC, Obrynba K, Kamboj MK, Hoffman RP. Identifying depressive symptoms among diabetes type and the impact on hemoglobin A1c. J Pediatr Endocrinol Metab. 2018 Jan 26; 31: 39-44.

View More Publications

Research

Publications

                  Miller JL, Gevers E, Bridges N, Yanovski JA, Salehi P, Obrynba KS, Felner EI, Bird LM, Shoemaker AH, Angulo M, Butler MG, Stevenson D, Abuzzahab J, Barrett T, Lah M, Littlejohn E, Mathew V, Cowen NM, Bhatnagar A. Diazoxide Choline Extended-Release Tablet in People with Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial. J Clin Endocrinol Metab. 2023 Jan 14;  

                


                  Roof E, Deal CL, McCandless SE, Cowan RL, Miller JL, Hamilton JK, Roeder ER, McCormack SE, Roshan Lal TR, Abdul-Latif HD, Haqq AM, Obrynba KS, Torchen LC, Vidmar AP, Viskochil DH, Chanoine JP, Lam CKL, Pierce MJ, Williams LL, Bird LM, Butler MG, Jensen DE, Myers SE, Oatman OJ, Baskaran C, Chalmers LJ, Fu C, Alos N, McLean SD, Shah A, Whitman BY, Blumenstein BA, Leonard SF, Ernest JP, Cormier JW, Cotter SP, Ryman DC. Intranasal Carbetocin Reduces Hyperphagia, Anxiousness and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial. J Clin Endocrinol Metab. 2023 Jan 12;  

                


                  Garey CJ, Clements MA, McAuliffe-Fogarty AH, Obrynba KS, Weinstock RS, Majidi S, Ross CS, Rioles NA. The association between depression symptom endorsement and glycemic outcomes in adolescents with type 1 diabetes. Pediatr Diabetes. 2021 Nov 14;  

                


                  Obrynba KS, Anglin K, Moffett A, Steinke T, Kamboj MK. A Quality Improvement Project to Implement Choking Prevention and First Aid Education in Prader-Willi Syndrome Caregivers. J Clin Med. 2021 Oct 27; 10: 

                


                  DeSalvo DJ, Noor N, Xie C, Corathers SD, Majidi S, McDonough RJ, Polsky S, Izquierdo R, Rioles N, Weinstock R, Obrynba K, Roberts A, Vendrame F, Sanchez J, Ebekozien O. Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data From T1D Exchange Real-World Observational Study. J Diabetes Sci Technol. 2021 Oct 9;  19322968211049783.

                


                  Prahalad P, Ebekozien O, Alonso GT, Clements M, Corathers S, DeSalvo D, Desimone M, Lee JM, Lorincz I, McDonough R, Majidi S, Odugbesan O, Obrynba K, Rioles N, Kamboj M, Jones NY, Maahs DM. Multi-Clinic Quality Improvement Initiative Increases Continuous Glucose Monitoring Use Among Adolescents and Young Adults With Type 1 Diabetes. Clin Diabetes. 2021 Jul; 39: 264-271.

                


                  Ginnard OZB, Alonso GT, Corathers SD, Demeterco-Berggren C, Golden LH, Miyazaki BT, Nelson G, Ospelt E, Ebekozien O, Lee JM, Obrynba KS, DeSalvo DJ. Quality Improvement in Diabetes Care: A Review of Initiatives and Outcomes in the T1D Exchange Quality Improvement Collaborative. Clin Diabetes. 2021 Jul; 39: 256-263.

                


                  Obrynba KS, Hoffman RP, Repaske DR, Anglin K, Kamboj MK. No central adrenal insufficiency found in patients with Prader-Willi syndrome with an overnight metyrapone test. J Pediatr Endocrinol Metab. 2018 Jul 26; 31: 809-814.

                


                  Glick BA, Hong KMC, Obrynba K, Kamboj MK, Hoffman RP. Identifying depressive symptoms among diabetes type and the impact on hemoglobin A1c. J Pediatr Endocrinol Metab. 2018 Jan 26; 31: 39-44.

View More Publications

Publications

                  Miller JL, Gevers E, Bridges N, Yanovski JA, Salehi P, Obrynba KS, Felner EI, Bird LM, Shoemaker AH, Angulo M, Butler MG, Stevenson D, Abuzzahab J, Barrett T, Lah M, Littlejohn E, Mathew V, Cowen NM, Bhatnagar A. Diazoxide Choline Extended-Release Tablet in People with Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial. J Clin Endocrinol Metab. 2023 Jan 14;  

                


                  Roof E, Deal CL, McCandless SE, Cowan RL, Miller JL, Hamilton JK, Roeder ER, McCormack SE, Roshan Lal TR, Abdul-Latif HD, Haqq AM, Obrynba KS, Torchen LC, Vidmar AP, Viskochil DH, Chanoine JP, Lam CKL, Pierce MJ, Williams LL, Bird LM, Butler MG, Jensen DE, Myers SE, Oatman OJ, Baskaran C, Chalmers LJ, Fu C, Alos N, McLean SD, Shah A, Whitman BY, Blumenstein BA, Leonard SF, Ernest JP, Cormier JW, Cotter SP, Ryman DC. Intranasal Carbetocin Reduces Hyperphagia, Anxiousness and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial. J Clin Endocrinol Metab. 2023 Jan 12;  

                


                  Garey CJ, Clements MA, McAuliffe-Fogarty AH, Obrynba KS, Weinstock RS, Majidi S, Ross CS, Rioles NA. The association between depression symptom endorsement and glycemic outcomes in adolescents with type 1 diabetes. Pediatr Diabetes. 2021 Nov 14;  

                


                  Obrynba KS, Anglin K, Moffett A, Steinke T, Kamboj MK. A Quality Improvement Project to Implement Choking Prevention and First Aid Education in Prader-Willi Syndrome Caregivers. J Clin Med. 2021 Oct 27; 10: 

                


                  DeSalvo DJ, Noor N, Xie C, Corathers SD, Majidi S, McDonough RJ, Polsky S, Izquierdo R, Rioles N, Weinstock R, Obrynba K, Roberts A, Vendrame F, Sanchez J, Ebekozien O. Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data From T1D Exchange Real-World Observational Study. J Diabetes Sci Technol. 2021 Oct 9;  19322968211049783.

                


                  Prahalad P, Ebekozien O, Alonso GT, Clements M, Corathers S, DeSalvo D, Desimone M, Lee JM, Lorincz I, McDonough R, Majidi S, Odugbesan O, Obrynba K, Rioles N, Kamboj M, Jones NY, Maahs DM. Multi-Clinic Quality Improvement Initiative Increases Continuous Glucose Monitoring Use Among Adolescents and Young Adults With Type 1 Diabetes. Clin Diabetes. 2021 Jul; 39: 264-271.

                


                  Ginnard OZB, Alonso GT, Corathers SD, Demeterco-Berggren C, Golden LH, Miyazaki BT, Nelson G, Ospelt E, Ebekozien O, Lee JM, Obrynba KS, DeSalvo DJ. Quality Improvement in Diabetes Care: A Review of Initiatives and Outcomes in the T1D Exchange Quality Improvement Collaborative. Clin Diabetes. 2021 Jul; 39: 256-263.

                


                  Obrynba KS, Hoffman RP, Repaske DR, Anglin K, Kamboj MK. No central adrenal insufficiency found in patients with Prader-Willi syndrome with an overnight metyrapone test. J Pediatr Endocrinol Metab. 2018 Jul 26; 31: 809-814.

                


                  Glick BA, Hong KMC, Obrynba K, Kamboj MK, Hoffman RP. Identifying depressive symptoms among diabetes type and the impact on hemoglobin A1c. J Pediatr Endocrinol Metab. 2018 Jan 26; 31: 39-44.

View More Publications

                  Miller JL, Gevers E, Bridges N, Yanovski JA, Salehi P, Obrynba KS, Felner EI, Bird LM, Shoemaker AH, Angulo M, Butler MG, Stevenson D, Abuzzahab J, Barrett T, Lah M, Littlejohn E, Mathew V, Cowen NM, Bhatnagar A. Diazoxide Choline Extended-Release Tablet in People with Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial. J Clin Endocrinol Metab. 2023 Jan 14;  

                


                  Roof E, Deal CL, McCandless SE, Cowan RL, Miller JL, Hamilton JK, Roeder ER, McCormack SE, Roshan Lal TR, Abdul-Latif HD, Haqq AM, Obrynba KS, Torchen LC, Vidmar AP, Viskochil DH, Chanoine JP, Lam CKL, Pierce MJ, Williams LL, Bird LM, Butler MG, Jensen DE, Myers SE, Oatman OJ, Baskaran C, Chalmers LJ, Fu C, Alos N, McLean SD, Shah A, Whitman BY, Blumenstein BA, Leonard SF, Ernest JP, Cormier JW, Cotter SP, Ryman DC. Intranasal Carbetocin Reduces Hyperphagia, Anxiousness and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial. J Clin Endocrinol Metab. 2023 Jan 12;  

                


                  Garey CJ, Clements MA, McAuliffe-Fogarty AH, Obrynba KS, Weinstock RS, Majidi S, Ross CS, Rioles NA. The association between depression symptom endorsement and glycemic outcomes in adolescents with type 1 diabetes. Pediatr Diabetes. 2021 Nov 14;  

                


                  Obrynba KS, Anglin K, Moffett A, Steinke T, Kamboj MK. A Quality Improvement Project to Implement Choking Prevention and First Aid Education in Prader-Willi Syndrome Caregivers. J Clin Med. 2021 Oct 27; 10: 

                


                  DeSalvo DJ, Noor N, Xie C, Corathers SD, Majidi S, McDonough RJ, Polsky S, Izquierdo R, Rioles N, Weinstock R, Obrynba K, Roberts A, Vendrame F, Sanchez J, Ebekozien O. Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data From T1D Exchange Real-World Observational Study. J Diabetes Sci Technol. 2021 Oct 9;  19322968211049783.

                


                  Prahalad P, Ebekozien O, Alonso GT, Clements M, Corathers S, DeSalvo D, Desimone M, Lee JM, Lorincz I, McDonough R, Majidi S, Odugbesan O, Obrynba K, Rioles N, Kamboj M, Jones NY, Maahs DM. Multi-Clinic Quality Improvement Initiative Increases Continuous Glucose Monitoring Use Among Adolescents and Young Adults With Type 1 Diabetes. Clin Diabetes. 2021 Jul; 39: 264-271.

                


                  Ginnard OZB, Alonso GT, Corathers SD, Demeterco-Berggren C, Golden LH, Miyazaki BT, Nelson G, Ospelt E, Ebekozien O, Lee JM, Obrynba KS, DeSalvo DJ. Quality Improvement in Diabetes Care: A Review of Initiatives and Outcomes in the T1D Exchange Quality Improvement Collaborative. Clin Diabetes. 2021 Jul; 39: 256-263.

                


                  Obrynba KS, Hoffman RP, Repaske DR, Anglin K, Kamboj MK. No central adrenal insufficiency found in patients with Prader-Willi syndrome with an overnight metyrapone test. J Pediatr Endocrinol Metab. 2018 Jul 26; 31: 809-814.

                


                  Glick BA, Hong KMC, Obrynba K, Kamboj MK, Hoffman RP. Identifying depressive symptoms among diabetes type and the impact on hemoglobin A1c. J Pediatr Endocrinol Metab. 2018 Jan 26; 31: 39-44.

View More Publications

  • Miller JL, Gevers E, Bridges N, Yanovski JA, Salehi P, Obrynba KS, Felner EI, Bird LM, Shoemaker AH, Angulo M, Butler MG, Stevenson D, Abuzzahab J, Barrett T, Lah M, Littlejohn E, Mathew V, Cowen NM, Bhatnagar A. Diazoxide Choline Extended-Release Tablet in People with Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial. J Clin Endocrinol Metab. 2023 Jan 14;
  • Roof E, Deal CL, McCandless SE, Cowan RL, Miller JL, Hamilton JK, Roeder ER, McCormack SE, Roshan Lal TR, Abdul-Latif HD, Haqq AM, Obrynba KS, Torchen LC, Vidmar AP, Viskochil DH, Chanoine JP, Lam CKL, Pierce MJ, Williams LL, Bird LM, Butler MG, Jensen DE, Myers SE, Oatman OJ, Baskaran C, Chalmers LJ, Fu C, Alos N, McLean SD, Shah A, Whitman BY, Blumenstein BA, Leonard SF, Ernest JP, Cormier JW, Cotter SP, Ryman DC. Intranasal Carbetocin Reduces Hyperphagia, Anxiousness and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial. J Clin Endocrinol Metab. 2023 Jan 12;
  • Garey CJ, Clements MA, McAuliffe-Fogarty AH, Obrynba KS, Weinstock RS, Majidi S, Ross CS, Rioles NA. The association between depression symptom endorsement and glycemic outcomes in adolescents with type 1 diabetes. Pediatr Diabetes. 2021 Nov 14;
  • Obrynba KS, Anglin K, Moffett A, Steinke T, Kamboj MK. A Quality Improvement Project to Implement Choking Prevention and First Aid Education in Prader-Willi Syndrome Caregivers. J Clin Med. 2021 Oct 27; 10:
  • DeSalvo DJ, Noor N, Xie C, Corathers SD, Majidi S, McDonough RJ, Polsky S, Izquierdo R, Rioles N, Weinstock R, Obrynba K, Roberts A, Vendrame F, Sanchez J, Ebekozien O. Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data From T1D Exchange Real-World Observational Study. J Diabetes Sci Technol. 2021 Oct 9; 19322968211049783.
  • Prahalad P, Ebekozien O, Alonso GT, Clements M, Corathers S, DeSalvo D, Desimone M, Lee JM, Lorincz I, McDonough R, Majidi S, Odugbesan O, Obrynba K, Rioles N, Kamboj M, Jones NY, Maahs DM. Multi-Clinic Quality Improvement Initiative Increases Continuous Glucose Monitoring Use Among Adolescents and Young Adults With Type 1 Diabetes. Clin Diabetes. 2021 Jul; 39: 264-271.
  • Ginnard OZB, Alonso GT, Corathers SD, Demeterco-Berggren C, Golden LH, Miyazaki BT, Nelson G, Ospelt E, Ebekozien O, Lee JM, Obrynba KS, DeSalvo DJ. Quality Improvement in Diabetes Care: A Review of Initiatives and Outcomes in the T1D Exchange Quality Improvement Collaborative. Clin Diabetes. 2021 Jul; 39: 256-263.
  • Obrynba KS, Hoffman RP, Repaske DR, Anglin K, Kamboj MK. No central adrenal insufficiency found in patients with Prader-Willi syndrome with an overnight metyrapone test. J Pediatr Endocrinol Metab. 2018 Jul 26; 31: 809-814.
  • Glick BA, Hong KMC, Obrynba K, Kamboj MK, Hoffman RP. Identifying depressive symptoms among diabetes type and the impact on hemoglobin A1c. J Pediatr Endocrinol Metab. 2018 Jan 26; 31: 39-44.

Education

Date of Appointment at Nationwide Children’s Hospital: 07/01/2010

Board Certifications

Pediatric Endocrinology Pediatrics

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2014

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/2010

Medical School

West Virginia University School of Medicine

Date Completed: 05/13/2007

Education

Date of Appointment at Nationwide Children’s Hospital: 07/01/2010

Board Certifications

Pediatric Endocrinology Pediatrics

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2014

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/2010

Medical School

West Virginia University School of Medicine

Date Completed: 05/13/2007

Education

Date of Appointment at Nationwide Children’s Hospital: 07/01/2010

Board Certifications

Pediatric Endocrinology Pediatrics

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2014

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/2010

Medical School

West Virginia University School of Medicine

Date Completed: 05/13/2007

Date of Appointment at Nationwide Children’s Hospital: 07/01/2010

Board Certifications

Pediatric Endocrinology Pediatrics

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2014

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/2010

Medical School

West Virginia University School of Medicine

Date Completed: 05/13/2007

Date of Appointment at Nationwide Children’s Hospital: 07/01/2010

Board Certifications

Pediatric Endocrinology Pediatrics

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2014

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/2010

Medical School

West Virginia University School of Medicine

Date Completed: 05/13/2007

  • Pediatric Endocrinology
  • Pediatrics

Contact Information

Pediatrics

Call us at: (614) 722-4425

Fax us at: (614) 722-4440

                    Endocrinology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Pediatrics

Call us at: (614) 722-4425

Fax us at: (614) 722-4440

                    Endocrinology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Pediatrics

Call us at: (614) 722-4425

Fax us at: (614) 722-4440

                    Endocrinology700 Children's DrColumbus, OH 43205 (map)

Pediatrics

Call us at: (614) 722-4425

Fax us at: (614) 722-4440

                    Endocrinology700 Children's DrColumbus, OH 43205 (map)

Call us at: (614) 722-4425

Fax us at: (614) 722-4440

                    Endocrinology700 Children's DrColumbus, OH 43205 (map)

Call us at: (614) 722-4425

Fax us at: (614) 722-4440

                    Endocrinology700 Children's DrColumbus, OH 43205 (map)
  • Call us at:
  • (614) 722-4425
  • Fax us at:
  • (614) 722-4440
  • Endocrinology700 Children’s DrColumbus, OH 43205 (map)